After Glaxo's genital herpes vaccine flop, check out Agenus Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : After Glaxo's genital herpes vaccine flop, check out Agenus

GSK 46.86

-0.2%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: albertaft	1/17/2015 5:17:43 PM
	Read Replies (1) of 22

GSK will explode to $100 a share in two weeks with Ebola vaccine. Strong buy on this one for January. $100 - $125 in the short term once the vaccine comes out , again which is about to happen.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next